A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: A short and practical regimen

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 4, 1998, Pages 696-701

  Wilairatana, Polrat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; MEFLOQUINE; SESQUITERPENE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MIDDLE AGED; THAILAND; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; SESQUITERPENES; THAILAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032227479     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Clinical trial of artesunate and artemether in multidrug resistant falciparum malaria in Thailand: a preliminary report. Southeast Asian J Trop Med Public Health 1991; 22: 380-5.
2. Handunnetti SM, Gunewardena DM, Pathirana PPSL, Ekanayake K, Weerasinghe S, Menais KN. Features of recrudescent chloroquine-resistant Plasmodium falcipamm infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med Hyg 1996; 90: 563-7.